Rising Incidence of Cancer Cases of Circulating Cell-Free Tumor DNA Market The global circulating cell-free tumor DNA Market is estimated to be valued at US$ 6.1 Bn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Circulating cell-free tumor DNA offers a non-invasive method for cancer screening, diagnosis, and...
0 Μοιράστηκε
351 Views
0 Προεπισκόπηση